1300015I baylor university; vteu; to 16-0057.C1D1.0058--15; zika can 8026799; $5,195,384

Ended Awarded Last action

Contract number
HHSN27200013
Awardee
Awarding agency
Obligated
$5,484,611

Award facts

Opportunity
Contract value 100% obligated
$5,484,610.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Houston, TX 77030, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00006 -$10,427
Supplemental Agreement for work within scope P00007 · 1300015I baylor college of medicine INC; vteu; to 13 (16-0057.C1D1.0058--15); deobligate line 2 and update various articles and clauses. -$226
Supplemental Agreement for work within scope P00008 · 1300015I baylor college of medicine INC; vteu; to 16-0057.C1D1.0058--15; zika can 8026799; $5,195,384. -$501
Other Administrative Action P00005 $0
Other Administrative Action P00004 · 1300015I baylor college of medicine INC; vteu; to 13 (16-0057.C1D1.0058--15); extend period of performance through 2/15/2022AND update various articles and… $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · 1300015I baylor university; vteu; to 13 (16-0057.C1D1.0058--15); extend period of performance and update various articles and clauses $0
Funding Only Action 1 $299,880
Original award $5,195,384

About this award

This federal contract award, valued at $5,484,610.82, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine as the prime contractor. The contract falls under the Vaccine and Treatment Evaluation Units (VTEU) program, which supports research and development of vaccines and treatments for infectious diseases.

The contract aims to implement a field trial and research laboratory to study the clinical outcomes, particularly neurological and neurodevelopmental, of postnatally acquired Zika virus infection in infants and children in Guatemala. Baylor College of Medicine serves as the prime contractor, with the University of Colorado-Denver and Emory University as major subcontractors. The contract does not have a set-aside designation, indicating Baylor's competitiveness in securing this federal work. This contract award demonstrates NIAID's continued investment in understanding and addressing the public health implications of the Zika virus outbreak.

Quick answers

Who was awarded contract HHSN27200013?

HHSN27200013 was awarded to Baylor College Of Medicine by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 18, 2017.

How much is contract HHSN27200013 worth?

The government has obligated $5,484,611 on HHSN27200013.

Is contract HHSN27200013 an order under another contract?

Yes. HHSN27200013 is a delivery order under HHSN272201300015I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200013 competed?

The extent of competition for HHSN27200013 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award